Symphony Asset Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-8,039
Closed -$676K 109
2019
Q4
$676K Sell
8,039
-165
-2% -$12.8K 0.15% 91
2019
Q3
$689K Sell
8,204
-5,507
-40% -$416K 0.15% 83
2019
Q2
$897K Buy
13,711
+3,458
+34% +$199K 0.19% 75
2019
Q1
$605K Buy
+10,253
New +$612K 0.16% 98

Other funds holding MEDP

Symphony Asset Management's MEDP Position: Q1 2020 in Review

Symphony Asset Management sold out of Medpace (MEDP) in Q1 2020, closing a stake of 8,039 shares — an estimated $676K sold.

Symphony Asset Management first reported a position in MEDP in Q1 2019 and held it in 4 quarters. The position peaked at $897K in Q2 2019. 269 funds tracked by Wall St. Rank hold MEDP as of Q1 2020.

  • Symphony Asset Management reported no remaining Medpace position as of Q1 2020 after selling out during the quarter.
  • Symphony Asset Management sold 8,039 Medpace shares in Q1 2020, an estimated $676K.
  • Symphony Asset Management first reported a position in Medpace in Q1 2019 and held it in 4 quarters.
  • Symphony Asset Management's Medpace position peaked at $897K in Q2 2019.
  • 269 funds tracked by Wall St. Rank held Medpace as of Q1 2020.

Based on Symphony Asset Management's 13F filing for Q1 2020, filed 12 May 2020.